FDA Approves A High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
Thu, 24 Dec 2009 06:27:00 -0600
The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.
Manage your FDA Subscriptions:
- Update your preferences or unsubscribe
- Questions about this service? support@xxxxxxxxxxxxxxx
- Other inquiries? webmail@xxxxxxxxxx
![Fight Flu with Facts! Visit flu.gov. Call 800-232-4636. Text FLU to 87000.](http://www.cdc.gov/emailupdates/images/h1n1emailcollab.gif)
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420